Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Jan. 15 (Bloomberg) –- PTC Therapeutics Chief Financial Officer Shane Kovacs discusses the drug his company is working on to treat Duchenne Muscular Dystrophy. He speaks to Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
On Air Now
SHOOTOUT: Can Nike Beat Adidas at Soccer?
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC